2.90
price down icon0.68%   -0.02
after-market アフターアワーズ: 2.87 -0.03 -1.03%
loading
前日終値:
$2.92
開ける:
$2.81
24時間の取引高:
367.24K
Relative Volume:
0.75
時価総額:
$139.56M
収益:
$230.47M
当期純損益:
$30.28M
株価収益率:
4.7541
EPS:
0.61
ネットキャッシュフロー:
$38.86M
1週間 パフォーマンス:
-7.64%
1か月 パフォーマンス:
-14.45%
6か月 パフォーマンス:
+9.43%
1年 パフォーマンス:
-47.37%
1日の値動き範囲:
Value
$2.7801
$2.94
1週間の範囲:
Value
$2.7801
$3.14
52週間の値動き範囲:
Value
$2.225
$6.055

Puma Biotechnology Inc Stock (PBYI) Company Profile

Name
名前
Puma Biotechnology Inc
Name
セクター
Healthcare (1172)
Name
電話
(424) 248-6500
Name
住所
10880 WILSHIRE BLVD., LOS ANGELES, CA
Name
職員
185
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
PBYI's Discussions on Twitter

PBYI を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
PBYI
Puma Biotechnology Inc
2.90 139.56M 230.47M 30.28M 38.86M 0.61
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 125.40B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 65.79B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 35.18B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 32.67B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 26.46B 3.81B -644.79M -669.77M -6.24

Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2021-09-28 アップグレード Citigroup Neutral → Buy
2020-06-25 再開されました BofA/Merrill Underperform
2019-10-08 ダウングレード Goldman Neutral → Sell
2019-05-10 ダウングレード Cantor Fitzgerald Overweight → Neutral
2019-05-10 ダウングレード Citigroup Buy → Neutral
2019-01-17 開始されました Leerink Partners Mkt Perform
2019-01-03 ダウングレード Guggenheim Buy → Neutral
2018-11-19 アップグレード Goldman Sell → Neutral
2018-11-02 ダウングレード BofA/Merrill Buy → Underperform
2018-11-02 ダウングレード JP Morgan Neutral → Underweight
2018-10-01 開始されました Cantor Fitzgerald Overweight
2018-09-17 開始されました Goldman Sell
2018-05-11 繰り返されました Stifel Buy
2017-11-10 繰り返されました Citigroup Buy
2017-11-10 繰り返されました RBC Capital Mkts Sector Perform
2017-10-02 繰り返されました Stifel Buy
2017-09-11 繰り返されました Credit Suisse Outperform
2017-07-10 再開されました Leerink Partners Outperform
2017-06-06 繰り返されました RBC Capital Mkts Sector Perform
2017-05-25 繰り返されました RBC Capital Mkts Sector Perform
2017-03-02 繰り返されました RBC Capital Mkts Sector Perform
すべてを表示

Puma Biotechnology Inc (PBYI) 最新ニュース

pulisher
Apr 03, 2025

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)April 2, 2025 - BioSpace

Apr 03, 2025
pulisher
Apr 02, 2025

Puma Biotech Expands Team: New Hires Receive Strategic Stock Compensation Package - Stock Titan

Apr 02, 2025
pulisher
Mar 29, 2025

Further weakness as Puma Biotechnology (NASDAQ:PBYI) drops 11% this week, taking five-year losses to 55% - simplywall.st

Mar 29, 2025
pulisher
Mar 27, 2025

Puma Biotechnology, Inc. (NASDAQ:PBYI) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? - Yahoo Finance

Mar 27, 2025
pulisher
Mar 26, 2025

Puma Biotechnology to Present Clinical Data on Neratinib at the AACR Annual Meeting 2025 - BioSpace

Mar 26, 2025
pulisher
Mar 26, 2025

Groundbreaking Clinical Trial: Neratinib's Novel Combination Approach Targets HER2 Tumors - Stock Titan

Mar 26, 2025
pulisher
Mar 20, 2025

Puma Biotechnology Stock Rises 35% in 6 Months: Here's Why - Nasdaq

Mar 20, 2025
pulisher
Mar 19, 2025

Puma Biotechnology Stock Rises 24% in 3 Months: Here's Why - MSN

Mar 19, 2025
pulisher
Mar 19, 2025

Why Investors Are Buzzing About Puma Biotechnology’s Earnings: Unpacking the Details - procarsrl.com.ar

Mar 19, 2025
pulisher
Mar 18, 2025

Puma Biotechnology (PBYI): One of the Best Short-Term Stocks to Buy Right Now - MSN

Mar 18, 2025
pulisher
Mar 12, 2025

Checking in on Puma Biotechnology Inc (PBYI) after recent insiders movement - Knox Daily

Mar 12, 2025
pulisher
Mar 11, 2025

Rhumbline Advisers Lowers Holdings in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Puma Biotechnology, Inc. (NASDAQ:PBYI) Held Back By Insufficient Growth Even After Shares Climb 26% - Simply Wall St

Mar 10, 2025
pulisher
Mar 10, 2025

Puma Biotechnology (NASDAQ:PBYI) Rating Lowered to Buy at StockNews.com - Armenian Reporter

Mar 10, 2025
pulisher
Mar 08, 2025

Puma Biotechnology (NASDAQ:PBYI) Stock Rating Lowered by StockNews.com - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

We Think Puma Biotechnology's (NASDAQ:PBYI) Healthy Earnings Might Be Conservative - Yahoo Finance

Mar 07, 2025
pulisher
Mar 06, 2025

Puma Biotech grants stock award to new hire By Investing.com - Investing.com Australia

Mar 06, 2025
pulisher
Mar 05, 2025

Puma Biotechnology, Inc. to Host Earnings Call - ACCESS Newswire

Mar 05, 2025
pulisher
Mar 05, 2025

Puma Biotechnology to Present at Barclays 27th Annual Global Healthcare Conference - BioSpace

Mar 05, 2025
pulisher
Mar 05, 2025

Puma Biotech grants stock award to new hire - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference - BioSpace

Mar 05, 2025
pulisher
Mar 05, 2025

Can Puma Biotechnology's Conference Presentation Signal New Growth Opportunities? - StockTitan

Mar 05, 2025
pulisher
Mar 04, 2025

Puma Biotechnology’s Earnings Call: Mixed Sentiments and Future Outlook - MSN

Mar 04, 2025
pulisher
Mar 03, 2025

Puma Biotechnology’s (PBYI) Buy Rating Reiterated at HC Wainwright - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

Results: Puma Biotechnology, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo

Mar 02, 2025
pulisher
Feb 28, 2025

PBYI Stock Rises as Q4 Earnings & Sales Outpace Estimates - Nasdaq

Feb 28, 2025
pulisher
Feb 28, 2025

Puma Biotechnology: Strong Financial Performance and Strategic Developments Justify Buy Rating - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

GoodRx Holdings Leads The Charge With These 3 Promising Penny Stocks - Simply Wall St

Feb 28, 2025
pulisher
Feb 28, 2025

Puma Biotechnology Inc (PBYI) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada

Feb 28, 2025
pulisher
Feb 28, 2025

Puma Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results - sharewise

Feb 28, 2025
pulisher
Feb 27, 2025

Puma Biotechnology Reports Strong Earnings Growth in 2024 - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Puma Biotech: Q4 Earnings Snapshot - CTPost

Feb 27, 2025
pulisher
Feb 27, 2025

Puma Biotechnology: Hold Rating Amidst Flat Sales Growth and Uncertain Drug Prospects - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Puma Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings call transcript: Puma Biotech Q4 2024 beats earnings expectations By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 27, 2025

Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings call transcript: Puma Biotech Q4 2024 beats earnings expectations - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

Puma Biotech stock rises as Q4 earnings surpass expectations By Investing.com - Investing.com Canada

Feb 27, 2025
pulisher
Feb 27, 2025

Puma Biotech stock rises as Q4 earnings surpass expectations - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

Puma Biotechnology Boosts Profits 57% While Revenue Dips: What's Behind This Earnings Paradox? - StockTitan

Feb 27, 2025
pulisher
Feb 26, 2025

Puma Biotechnology to Present at TD Cowen’s 45th Annual Health Care Conference - BioSpace

Feb 26, 2025
pulisher
Feb 26, 2025

Puma Biotechnology Reveals Corporate Strategy at Major Healthcare ConferenceWhat Will CEO Disclose? - StockTitan

Feb 26, 2025
pulisher
Feb 25, 2025

Puma Biotechnology Inc expected to post earnings of 10 cents a shareEarnings Preview - TradingView

Feb 25, 2025
pulisher
Feb 23, 2025

Investors in Puma Biotechnology (NASDAQ:PBYI) have unfortunately lost 73% over the last five years - Yahoo Finance

Feb 23, 2025

Puma Biotechnology Inc (PBYI) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Puma Biotechnology Inc (PBYI) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Ludwig Jeffrey Jerome
Chief Commercial Officer
Jan 02 '25
Sale
3.15
9,437
29,743
108,951
HUNT DOUGLAS M
See Remarks
Jan 02 '25
Sale
3.15
8,633
27,209
124,594
AUERBACH ALAN H
President and CEO
Jan 02 '25
Sale
3.15
33,841
106,657
7,029,674
$60.26
price down icon 10.70%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
大文字化:     |  ボリューム (24 時間):